Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Gridelli, C.
Right arrow Articles by De Marinis, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gridelli, C.
Right arrow Articles by De Marinis, F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 12:S21-S25, 2001
© 2001 European Society for Medical Oncology

Symposium Article

Quality of life in lung cancer patients

C. Gridelli1, F. Perrone2, F. Nelli3, S. Ramponi3 and F. De Marinis3

1 Divisione di Oncologia Medica B, Istituto Nazionale Tumori Naples
2 Ufficio Sperimentazioni Cliniche Controllate, Istituto Nazionale Napoli
3 5 Unità Pneumologia, Ospedale S. Camillo-Forlanini Rome, Italy

Correspondence to: C. Gridelli, MD Divisione di Oncologia Medica B Istituto Nazionale Tumori Via M. Semmola 80131, Naples Italy E-mail: cgridelli{at}sino-oncology.it

The quality of life of lung cancer patients is affected by several factors related to the patients, stage of disease and treatment characteristics. For small-cell lung cancer (SCLC), the treatment is generally aggressive, primarily based on chemotherapy. Treatment strategy for non-small-cell lung cancer (NSCLC) is strongly dependent on the stage of the disease and ranges from surgery to palliative chemotherapy. Over the last few years, very little progress has been made in terms of survival. Therefore, the effect of treatment on quality of life has become progressively more relevant. Among the instruments for measuring quality of life, there are some specifically developed for lung cancer, such as the European Organization for Research and Treatment of Cancer (EORTC) LC-13 questionnaire, the Functional Assessment of Cancer Therapy (FACT-L) questionnaire and the Lung Cancer Symptom Scale (LCSS). Up to now, few randomised clinical trials have correctly evaluated quality of life. There are evident pitfalls associated with the use of frequently non-validated tools, and poor methods of data analysis, but quality-of-life evaluation is crucial and should be addressed through well-planned and well-conducted prospective clinical trials.

non-small-cell lung cancer, quality of life, small-cell lung cancer


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Mayo Clin Proc.Home page
A. Svobodnik, P. Yang, P. J. Novotny, E. Bass, Y. I. Garces, J. R. Jett, J. A. Bonner, and J. A. Sloan
Quality of Life in 650 Lung Cancer Survivors 6 Months to 4 Years After Diagnosis
Mayo Clin. Proc., August 1, 2004; 79(8): 1024 - 1030.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.